Ronald L. Stephens

3.4k citations

83 papers · 2.6k indexed · 1 hit paper · h-index 24

Impact in

Oncology top 2%
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Oncology 41
- Cancer Treatment and Pharmacology 13
- Lung Cancer Research Studies 11
- Colorectal Cancer Treatments and Studies 6
Pathology and Forensic Medicine 16
- Lymphoma Diagnosis and Treatment 11

Co-authors: Charles A. Coltman Stephen E. Jones P Grozea Arthur Haut Thomas E. Moon Michael K. Samson Robert W. Talley Montague Lane
Journals: Cancer (17 papers)Investigational New Drugs (9 papers)Journal of Clinical Oncology (6 papers)The American Journal of Medicine (5 papers)The Journal of Urology (4 papers)
Partner nations: United States

In The Last Decade

Ronald L. Stephens

83 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma 1976 · 625 citations

Peers

Countries citing papers authored by Ronald L. Stephens

Since Specialization

Citations

This map shows the geographic impact of Ronald L. Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald L. Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald L. Stephens more than expected).

Fields of papers citing papers by Ronald L. Stephens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald L. Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald L. Stephens. The network helps show where Ronald L. Stephens may publish in the future.

Co-authors

The 25 scholars most cited alongside Ronald L. Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald L. Stephens Line = papers co-authored together Ronald L. Stephens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Addition of Tamoxifen to Dacarbazine and Cisplatin in Metastatic Malignant Melanoma American Journal of Clinical Oncology ·Lawrence E. Flaherty, P. Y. Liu, Malcolm S. Mitchell, William S. Fletcher, Michael J. Walker, J. Wendall Goodwin, Ronald L. Stephens, Vernon K. Sondak	1996	14
2	Phase II trial of menogaril in metastatic adenocarcinoma of the prostate Investigational New Drugs ·Sarah A. Taylor, Brent A. Blumenstein, Ronald L. Stephens, E. David Crawford, Bernie Pistone, Julian B. Hill	1994	3
3	Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer The Journal of Urology ·Raj Sadasivan, R.J. Morgan, Scott Jennings, M Austenfeld, Peter J. Van Veldhuizen, Ronald L. Stephens, M Noble	1993	101
4	Mutant p53 expression in prostate carcinoma The Prostate ·Peter J. Van Veldhuizen, Raj Sadasivan, Fernando U. Garcia, Mark S. Austenfeld, Ronald L. Stephens	1993	63
5	p53 Expression in Incidental Prostatic Cancer The American Journal of the Medical Sciences ·Peter J. Van Veldhuizen, Raj Sadasivan, Rachel Cherian, Tim Dwyer, Ronald L. Stephens	1993	23
6	Treatment of stages B3 and C seminoma with chemotherapy followed by irradiation therapy Urology ·E. David Crawford, Phyllis J. Goodman, William L. Nabors, Ronald L. Stephens, K. Khan, Lawrence M. Pass, Anthony Y. Smith, Debra W. Christie	1992	3
7	Breast Cancer in Males—A Genetic Consideration The American Journal of the Medical Sciences ·Ronald L. Stephens, R. Neil Schimke	1992	4
8	Dacarbazine and Outpatient Interleukin-2 in Treatment of Metastatic Malignant Melanoma: Phase II Southwest Oncology Group Trial JNCI Journal of the National Cancer Institute ·Lawrence E. Flaherty, Pengfei Liu, William S. Fletcher, J. Wendall Goodwin, S P Balcerzak, Donald V. Daniels, Ronald L. Stephens, Vernon K. Sondak	1992	10
9	A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. Journal of Clinical Oncology ·Agnieszka Woźniak, Michael K. Samson, Neal Shah, E. David Crawford, Carole Ford, Stanley J. Altman, Ronald L. Stephens, Ronald B. Natale, Bertha A. Bouroncle, Brent A. Blumenstein	1991	31
10	Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study Cancer Chemotherapy and Pharmacology ·Steven M. Grunberg, John J. Crowley, Robert B. Livingston, Franco M. Muggia, John S. Macdonald, Stephen K. Williamson, Ronald L. Stephens	1991	3
11	Phase II Study of Fludarabine Phosphate (NSC-312887) in Patients with Advanced Endometrial Cancer American Journal of Clinical Oncology ·Daniel D. Von Hoff, Stephanie Green, David S. Alberts, Donna Stock-Novack, Earl A. Surwit, Thomas P. Miller, Ronald L. Stephens	1991	12
12	Phase II evaluation of bisantrene in refractory multiple myeloma Investigational New Drugs ·Brian G.M. Durie, John Crowley, Charles A. Coltman, Robert Chapman, Stanley P. Balcerzk, John D. Bonnet, David A. Lipschitz, Ronald L. Stephens, Bruce D. Cheson	1991	4
13	Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group Study JNCI Journal of the National Cancer Institute ·John D. Cowan, Jeffrey D. Neidhart, Suzanne McClure, Charles A. Coltman, Conrad H. Gumbart, S Martino, Laura F. Hutchins, Ronald L. Stephens, C. B. Vaughan, C. Kent Osborne	1991	62
14	Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study. Journal of Clinical Oncology ·Charles W. Taylor, John Crowley, Stephen K. Williamson, TP Miller, S A Taylor, T G Giri, Ronald L. Stephens, Robert B. Livingston	1990	29
15	A phase II trial of continuous infusion vinblastine in patients with gastric carcinoma European Journal of Cancer and Clinical Oncology ·Daniel D. Von Hoff, Phylis J. Goodman, Cary A. Presant, Robert L. Ruxer, John S. Macdonald, John J. Costanzi, Ronald L. Stephens, Stanley Vogel	1990	3
16	Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: A Southwest Oncology Group Study International Journal of Radiation OncologyBiologyPhysics ·Joaquin G. Mira, Sarah L. Taylor, Ronald L. Stephens, Timothy F. Chen	1988	10
17	Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. Journal of Clinical Oncology ·Frank J. Panettiere, Phyllis J. Goodman, J J Costanzi, Anatolio B. Cruz, V. K. Vaitkevicius, Joseph D. McCracken, Robert Brownlee, Leslie R. Laufman, Ronald L. Stephens, John D. Bonnet	1988	61
18	Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Ronald L. Stephens, Barth Hoogstraten, Charles D. Haas, Gary M. Clark	1978	6
19	Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D. PubMed ·Stuart C. Spigel, Ronald L. Stephens, Charles D. Haas, H. Savage Jones, Daniel E. Lehane, Thomas E. Moon, Charles A. Coltman	1978	8
20	Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Bill L. Tranum, Ronald L. Stephens, Daniel E. Lehane, Barth Hoogstraten, M. Daniel Lane, Arthur Haut	1975	1

About Ronald L. Stephens

Ronald L. Stephens is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Reproductive Medicine, having authored 83 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Testicular diseases and treatments (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Lung Cancer Research Studies (11 papers), Neuroendocrine Tumor Research Advances (10 papers), Cancer therapeutics and mechanisms (8 papers), Prostate Cancer Treatment and Research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (1.3k citations), Pathology and Forensic Medicine (813 citations), Genetics (317 citations), Neurology (437 citations) and Hematology (227 citations). Ronald L. Stephens has collaborated with scholars based in United States. Frequent co-authors include Charles A. Coltman, Stephen E. Jones, P Grozea, Arthur Haut, Thomas E. Moon, Michael K. Samson, Robert W. Talley, Montague Lane, Henry E. Wilson and Eugene M. McKelvey. Their work appears in journals such as Cancer, Investigational New Drugs, Journal of Clinical Oncology, The American Journal of Medicine and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact